WEBINAR ENDED
WEBINAR DETAILS
  • About
    Join Aptahem AB for a webinar where the company will present its ongoing preparations for a planned U.S. listing. During the session, management will outline the strategic initiatives undertaken to strengthen the company’s position, attract U.S. institutional investors, and create optimal conditions for financing the upcoming Phase 2 study.
  • Agenda
    • FDA PreCheck Program
    • Expansion of U.S. Intellectual Property Rights
    • Initiatives for Accelerated Regulatory Review in the U.S.
    • Planned U.S. Listing
  • Duration
    1 hour
  • Price
    Free
  • Language
    English
  • OPEN TO
    Everyone
  • Dial-in available
    (listen only)
    Not available.
HOSTED BY
Powered by BigMarker